M. Ekpenyong, Stephen Alfred, Bosu-Arije Foluke, Oley Jallow, C. Manju, Nyashanu Mathew
Introduction: In the UK, the number of people diagnosed with renal disease is on the increase. As a result, there will be more people in need of renal replacement therapy (RRT). Despite the mounting evidence showing that home hemodialysis (HHD) treatment is clinical and cost-effective as well as amendable to suit patients' lifestyle, the number of patients choosing this dialysis modality is low. The aim of this study is to explore factors influencing decision-making process in the selection of HHD treatment for adult patients with end-stage renal disease in the UK. Methods: A systematic literature review methodology was utilized to review, critique, and synthesize the literature on the low uptake of HHD among adult patients. Systematic searches involving the databases Google Scholar, EMBASE, MEDLINE, PsycINFO, and CINAHL were carried out for articles published from 2008 to 2021. A search was conducted from June 1 through December 23, 2020. Eight articles met the study inclusion criteria. We followed preferred Reporting Items for Systematic Reviews and Meta-analyses in designing the research and reporting. Results: This systematic review revealed that patient information needs, dialysis education, training and support, and patient decision-making preference were the major factors influencing decision-making of adult patients. Conclusion: Deciding over which dialysis modality to choose can be challenging for many adult patients. Dialysis education, training, and support should not stop at the predialysis stage but should continue during treatment.
{"title":"Decision-making process in the selection of home hemodialysis treatment by adult patients with end-stage renal disease in the United Kingdom: A systematic literature review","authors":"M. Ekpenyong, Stephen Alfred, Bosu-Arije Foluke, Oley Jallow, C. Manju, Nyashanu Mathew","doi":"10.4103/cjhr.cjhr_69_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_69_22","url":null,"abstract":"Introduction: In the UK, the number of people diagnosed with renal disease is on the increase. As a result, there will be more people in need of renal replacement therapy (RRT). Despite the mounting evidence showing that home hemodialysis (HHD) treatment is clinical and cost-effective as well as amendable to suit patients' lifestyle, the number of patients choosing this dialysis modality is low. The aim of this study is to explore factors influencing decision-making process in the selection of HHD treatment for adult patients with end-stage renal disease in the UK. Methods: A systematic literature review methodology was utilized to review, critique, and synthesize the literature on the low uptake of HHD among adult patients. Systematic searches involving the databases Google Scholar, EMBASE, MEDLINE, PsycINFO, and CINAHL were carried out for articles published from 2008 to 2021. A search was conducted from June 1 through December 23, 2020. Eight articles met the study inclusion criteria. We followed preferred Reporting Items for Systematic Reviews and Meta-analyses in designing the research and reporting. Results: This systematic review revealed that patient information needs, dialysis education, training and support, and patient decision-making preference were the major factors influencing decision-making of adult patients. Conclusion: Deciding over which dialysis modality to choose can be challenging for many adult patients. Dialysis education, training, and support should not stop at the predialysis stage but should continue during treatment.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44104993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Goiter is defined as abnormal (either nodular or diffuse) growth of the thyroid gland. The normal thyroid gland is located in neck, caudal to larynx in anterolateral portion of the trachea. Intrathoracic goiter, defined as growth of more than 50% of the thyroid gland below the thoracic operculum, mostly located in anterior mediastinum and is seen in only 8%–15% of all goiters. Posterior mediastinal goiters (PMGs) are rare and accounts for only 2% of intrathoracic goiters. Patients usually present with a cervical mass and local pressure symptoms due to tracheal, esophageal, or superior vena cava compression. The diagnosis is established by chest X-ray, computed tomography scan, and fine-needle aspiration cytology. A combined cervicothoracic approach is the procedure of choice as it provides easy access, better visualization, and optimal control of blood vessels. We, hereby, describe a case of giant PMG, which was managed successfully at our center.
{"title":"A giant posterior mediastinal goiter","authors":"Ajin Anto, Surjeet Dwivedi, Raj Mohan, Rakesh Jha","doi":"10.4103/cjhr.cjhr_86_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_86_22","url":null,"abstract":"Goiter is defined as abnormal (either nodular or diffuse) growth of the thyroid gland. The normal thyroid gland is located in neck, caudal to larynx in anterolateral portion of the trachea. Intrathoracic goiter, defined as growth of more than 50% of the thyroid gland below the thoracic operculum, mostly located in anterior mediastinum and is seen in only 8%–15% of all goiters. Posterior mediastinal goiters (PMGs) are rare and accounts for only 2% of intrathoracic goiters. Patients usually present with a cervical mass and local pressure symptoms due to tracheal, esophageal, or superior vena cava compression. The diagnosis is established by chest X-ray, computed tomography scan, and fine-needle aspiration cytology. A combined cervicothoracic approach is the procedure of choice as it provides easy access, better visualization, and optimal control of blood vessels. We, hereby, describe a case of giant PMG, which was managed successfully at our center.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47078236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kallol Paul, P. Halder, Rituparna Das, Arpita Choudhury, Prerna Goenka, Sourav Roy
Background: Pacifying newborns by nonpharmacological methods during painful procedures is a frequent and difficult problem in routine practice. Purpose: The purpose of the study was to determine the analgesic effects of oral sucrose solution in comparison to placebo (sterile water) in neonates. Materials and Methods: A prospective, double-blinded study of 100 neonates who were divided into two groups after simple randomization, to give either 30% sucrose solution (group A) or sterile water (group B) during an intravenous catheterization. Assessment of pain by the Douleur Aigue Nouveau-ne scale (DAN) and changes in the heart rate (HR), respiratory rate (RR), or arterial oxygen saturation (SpO2) during peripheral vein catheterization were analyzed. Results: The mean change of HR, RR, and SpO2 was more in group B compared to group A. The mean DAN scores were 2.24 ± 2.026 and 6.92 ± 2.538 in group A and group B, respectively. None of these results were statistically significant (P > 0.05). Conclusion: There was a less prominent change in HR, RR, and SpO2 with response to noxious stimuli with oral sucrose administration in newborns when compared to placebo.
{"title":"Evaluation of the analgesic effect of oral sucrose solution on neonates undergoing a minor painful procedure","authors":"Kallol Paul, P. Halder, Rituparna Das, Arpita Choudhury, Prerna Goenka, Sourav Roy","doi":"10.4103/cjhr.cjhr_14_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_14_22","url":null,"abstract":"Background: Pacifying newborns by nonpharmacological methods during painful procedures is a frequent and difficult problem in routine practice. Purpose: The purpose of the study was to determine the analgesic effects of oral sucrose solution in comparison to placebo (sterile water) in neonates. Materials and Methods: A prospective, double-blinded study of 100 neonates who were divided into two groups after simple randomization, to give either 30% sucrose solution (group A) or sterile water (group B) during an intravenous catheterization. Assessment of pain by the Douleur Aigue Nouveau-ne scale (DAN) and changes in the heart rate (HR), respiratory rate (RR), or arterial oxygen saturation (SpO2) during peripheral vein catheterization were analyzed. Results: The mean change of HR, RR, and SpO2 was more in group B compared to group A. The mean DAN scores were 2.24 ± 2.026 and 6.92 ± 2.538 in group A and group B, respectively. None of these results were statistically significant (P > 0.05). Conclusion: There was a less prominent change in HR, RR, and SpO2 with response to noxious stimuli with oral sucrose administration in newborns when compared to placebo.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49086590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
COVID-19 epidemic severely affects the social life of people living in India. The best solution to the COVID-19 problem is the vaccination of the people. In India, COVID-19 vaccination started from January 16, 2021, mainly with the Covishield vaccine. In this study, the COVID-positive history family was selected who had taken the first and second (booster) doses residing at Pune, Maharashtra, India, was followed up to check for any side effects postvaccination. Their data were collected with participant-administered questions. The predominant side effects reported were uneasiness, pyrexia (fever), voice difference, vomiting, and headache. The side effects were started at 2–16 h postvaccination while it takes an average duration of 48–60 h to last. Analysis shows nonpresence of major and serious side effects makes the Covidshield vaccine safe for use in the COVID-positive history population.
{"title":"Complexities of Covishield Vaccine on COVID-Positive History Family in India after the Second (Booster) Dose","authors":"P. Jamdade, S. Jamdade","doi":"10.4103/cjhr.cjhr_50_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_50_22","url":null,"abstract":"COVID-19 epidemic severely affects the social life of people living in India. The best solution to the COVID-19 problem is the vaccination of the people. In India, COVID-19 vaccination started from January 16, 2021, mainly with the Covishield vaccine. In this study, the COVID-positive history family was selected who had taken the first and second (booster) doses residing at Pune, Maharashtra, India, was followed up to check for any side effects postvaccination. Their data were collected with participant-administered questions. The predominant side effects reported were uneasiness, pyrexia (fever), voice difference, vomiting, and headache. The side effects were started at 2–16 h postvaccination while it takes an average duration of 48–60 h to last. Analysis shows nonpresence of major and serious side effects makes the Covidshield vaccine safe for use in the COVID-positive history population.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41861665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01DOI: 10.4103/cjhr.cjhr_105_22
Ebenezer Daniel, B. Yadav, L. Jeyaseelan, M. Babu, Selvin Raj Mani, A. Mathuram, S. Sathyendra, S. Hansdak, R. Iyyadurai, R. Sahni, T. Sudarsanam
Background and Objectives: Upper urinary tract infections (UTIs) that require in-patient care can be expensive. Comorbid conditions such as diabetes as well as UTI due to extended-spectrum beta-lactamase (ESBL) producing bacteria may affect costs. The quality of life of patients with this condition has not been described. Methods: This was a cost of illness study that prospectively evaluated patients admitted with upper UTI to a medical ward in a tertiary care hospital. Direct medical and nonmedical costs, indirect costs were collected to make the total cost per admission. Quality of life was assessed using the World Health Organization Quality of Life-BREF score. We also compared costs between those with and without diabetes or ESBL infection. Results: Between March 2016 and July 2017, 92 eligible patients were included in the study. The average age was 55.8 years; two thirds were diabetics. The mean overall cost of a single admission for upper UTI was INR.88, 330.2 (1370.4 USD). This was INR.96, 193.0 (1492.6 USD) and INR.1, 03,154.9 (1600.4 USD) among those with diabetes mellitus and ESBL infection, respectively. The cost was higher among those with diabetes and ESBL than those without; this difference reached statistically significance for the ESBL group. The quality of life was affected in all domains; the psychological being most affected among diabetics and ESBL infected. Conclusions: The mean total cost of admission for an upper UTI in a tertiary care hospital in South India was INR 88,330 (1370.4 USD). This is higher if the patient has diabetes or ESBL organism causing the UTI. Quality of life is clearly reduced especially in the psychological domain.
{"title":"Cost of care and impact on quality of life of upper urinary tract infections in South India with a focus on diabetics and extended-spectrum beta-lactam producing organisms","authors":"Ebenezer Daniel, B. Yadav, L. Jeyaseelan, M. Babu, Selvin Raj Mani, A. Mathuram, S. Sathyendra, S. Hansdak, R. Iyyadurai, R. Sahni, T. Sudarsanam","doi":"10.4103/cjhr.cjhr_105_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_105_22","url":null,"abstract":"Background and Objectives: Upper urinary tract infections (UTIs) that require in-patient care can be expensive. Comorbid conditions such as diabetes as well as UTI due to extended-spectrum beta-lactamase (ESBL) producing bacteria may affect costs. The quality of life of patients with this condition has not been described. Methods: This was a cost of illness study that prospectively evaluated patients admitted with upper UTI to a medical ward in a tertiary care hospital. Direct medical and nonmedical costs, indirect costs were collected to make the total cost per admission. Quality of life was assessed using the World Health Organization Quality of Life-BREF score. We also compared costs between those with and without diabetes or ESBL infection. Results: Between March 2016 and July 2017, 92 eligible patients were included in the study. The average age was 55.8 years; two thirds were diabetics. The mean overall cost of a single admission for upper UTI was INR.88, 330.2 (1370.4 USD). This was INR.96, 193.0 (1492.6 USD) and INR.1, 03,154.9 (1600.4 USD) among those with diabetes mellitus and ESBL infection, respectively. The cost was higher among those with diabetes and ESBL than those without; this difference reached statistically significance for the ESBL group. The quality of life was affected in all domains; the psychological being most affected among diabetics and ESBL infected. Conclusions: The mean total cost of admission for an upper UTI in a tertiary care hospital in South India was INR 88,330 (1370.4 USD). This is higher if the patient has diabetes or ESBL organism causing the UTI. Quality of life is clearly reduced especially in the psychological domain.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42860294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bhawani Parihar, R. Agrawal, Vijendra Garg, Jagdish Singh, A. Goyal, Raj Gupta, S. Gothwal
Introduction: Although ventilator-associated pneumonia (VAP) mostly has bacterial etiology, many cases have viral etiology. The present study aimed at determining the proportion of viral VAP and any associated factors and identifying the viral isolates in pediatric VAP. Materials and Methods: A descriptive observational study was conducted at pediatric intensive care unit of tertiary referral center including 120 VAP cases aged 1–18 years. Endotracheal aspiration samples from these patients were tested for viral etiology. Results: Most VAP cases were males (66.7%). Virus was isolated in 14.2% of cases of VAP. Human adenovirus (29%), respiratory syncytial virus (29%), and herpes simplex virus (24%) were the most common viruses identified. Viral VAP was significantly associated with age, primary disease, and total leukocyte count. Neutrophil count decreased and lymphocyte count increased significantly after viral VAP. Conclusion: Viral etiology should be considered in VAP patients, especially in patients not responding to antibiotics as proper diagnosis and timely initiation of appropriate antiviral could be lifesaving. Prevalent viruses may vary geographically; hence, hospitals should try to identify the common viruses causing VAP in their settings to guide appropriate battery of tests and antiviral drugs.
{"title":"Viral isolates in pediatric ventilator-associated pneumonia","authors":"Bhawani Parihar, R. Agrawal, Vijendra Garg, Jagdish Singh, A. Goyal, Raj Gupta, S. Gothwal","doi":"10.4103/cjhr.cjhr_30_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_30_22","url":null,"abstract":"Introduction: Although ventilator-associated pneumonia (VAP) mostly has bacterial etiology, many cases have viral etiology. The present study aimed at determining the proportion of viral VAP and any associated factors and identifying the viral isolates in pediatric VAP. Materials and Methods: A descriptive observational study was conducted at pediatric intensive care unit of tertiary referral center including 120 VAP cases aged 1–18 years. Endotracheal aspiration samples from these patients were tested for viral etiology. Results: Most VAP cases were males (66.7%). Virus was isolated in 14.2% of cases of VAP. Human adenovirus (29%), respiratory syncytial virus (29%), and herpes simplex virus (24%) were the most common viruses identified. Viral VAP was significantly associated with age, primary disease, and total leukocyte count. Neutrophil count decreased and lymphocyte count increased significantly after viral VAP. Conclusion: Viral etiology should be considered in VAP patients, especially in patients not responding to antibiotics as proper diagnosis and timely initiation of appropriate antiviral could be lifesaving. Prevalent viruses may vary geographically; hence, hospitals should try to identify the common viruses causing VAP in their settings to guide appropriate battery of tests and antiviral drugs.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44035850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lymphangioma circumscriptum is a microcystic lymphatic malformation localized to an area of the skin, subcutaneous tissue, and muscle which presents with vesiculo-papules or warty lesions, resembling a “frog spawn.” Keloids develop due to the proliferation of dermal tissue following skin injury. We present a case of lymphangioma circumscriptum with secondary infection and keloid formation treated with intralesional bleomycin.
{"title":"Effect of injection bleomycin on lymphangioma circumscriptum with keloid formation and secondary infection","authors":"A. Thomas, E. Thomas, Abhilasha Williams","doi":"10.4103/cjhr.cjhr_84_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_84_22","url":null,"abstract":"Lymphangioma circumscriptum is a microcystic lymphatic malformation localized to an area of the skin, subcutaneous tissue, and muscle which presents with vesiculo-papules or warty lesions, resembling a “frog spawn.” Keloids develop due to the proliferation of dermal tissue following skin injury. We present a case of lymphangioma circumscriptum with secondary infection and keloid formation treated with intralesional bleomycin.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46919304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bhavin Prajapati, P. Gohel, Atit Shah, H. Shah, Kaival K Kothari, Jayshri Pethani
Introduction: Respiratory infections are associated with high morbidity and mortality, especially in critically ill patients. The excessive use of broad-spectrum antibiotics has led to the development of drug resistance, thus resulting in the emergence of pathogens which are difficult to treat. Materials and Methods: A total of 632 tracheal secretions were received in the Bacteriology section of the microbiology department of a tertiary care hospital from November 2019 to February 2020. Tracheal secretions were processed for culture according to standard operating procedures. Identification, phenotype detection, and antibiotic sensitivity testing were performed by automated VITEK-2 Compact system. Results: In total, 632 tracheal secretions were received during the study period, 559 cultures yielded significant pathogens and no organisms were isolated in 73 cultures. Among the Gram-negative organism 540 (97%), Klebsiella pneumoniae (30%) was the most common isolates. Gram-positive organisms 12 (2%) and Candida spp. 7 (1%) were isolated. The most common phenotype detected in Escherichia coli and K. pneumoniae was extended-spectrum beta-lactamase producer. Conclusions: K. pneumoniae was the most common isolate from tracheal secretion among intensive care unit patients. Colistin, followed by tigecycline, was found to be the most susceptible antibiotics. K. pneumoniae was found to be sensitive to tigecycline (69%) with minimum inhibitory concentrations of ≤ 1. 0.6%. K. pneumoniae was colistin resistant.
{"title":"Bacteriological Profile and antibiotic susceptibility pattern of tracheal secretions isolates among intensive care unit patients at tertiary care hospital","authors":"Bhavin Prajapati, P. Gohel, Atit Shah, H. Shah, Kaival K Kothari, Jayshri Pethani","doi":"10.4103/cjhr.cjhr_9_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_9_22","url":null,"abstract":"Introduction: Respiratory infections are associated with high morbidity and mortality, especially in critically ill patients. The excessive use of broad-spectrum antibiotics has led to the development of drug resistance, thus resulting in the emergence of pathogens which are difficult to treat. Materials and Methods: A total of 632 tracheal secretions were received in the Bacteriology section of the microbiology department of a tertiary care hospital from November 2019 to February 2020. Tracheal secretions were processed for culture according to standard operating procedures. Identification, phenotype detection, and antibiotic sensitivity testing were performed by automated VITEK-2 Compact system. Results: In total, 632 tracheal secretions were received during the study period, 559 cultures yielded significant pathogens and no organisms were isolated in 73 cultures. Among the Gram-negative organism 540 (97%), Klebsiella pneumoniae (30%) was the most common isolates. Gram-positive organisms 12 (2%) and Candida spp. 7 (1%) were isolated. The most common phenotype detected in Escherichia coli and K. pneumoniae was extended-spectrum beta-lactamase producer. Conclusions: K. pneumoniae was the most common isolate from tracheal secretion among intensive care unit patients. Colistin, followed by tigecycline, was found to be the most susceptible antibiotics. K. pneumoniae was found to be sensitive to tigecycline (69%) with minimum inhibitory concentrations of ≤ 1. 0.6%. K. pneumoniae was colistin resistant.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41719320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Transgender reproductive medicine: Need for the near future","authors":"R. Baid","doi":"10.4103/cjhr.cjhr_35_22","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_35_22","url":null,"abstract":"","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41723279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-07-01DOI: 10.4103/cjhr.cjhr_115_21
R. Kadni, M. Mathews
{"title":"An unprecedented presentation of foreign body","authors":"R. Kadni, M. Mathews","doi":"10.4103/cjhr.cjhr_115_21","DOIUrl":"https://doi.org/10.4103/cjhr.cjhr_115_21","url":null,"abstract":"","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48778124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：